What Patients with Bladder Cancer Can Do When COVID-19 Impacts Their Care

Video

COVID-19 has drastically changed the landscape for patients with bladder cancer, but the new challenges are not insurmountable. CURE had the chance to interview the co-founder of the Bladder Cancer Advocacy Network to discuss these changes.

There are as many approaches to bladder cancer treatment as there are types of the disease. But for patients who are struggling with treatment decisions due to the COVID-19 pandemic, the key lies in constant communication with their healthcare team, says one expert.

CURE® recently spoke with Bladder Cancer Advocacy Network co-founder Diane Zipursky Quale about the challenges that patients with bladder cancer are currently facing because of the pandemic, and how doctors are working with patients to come up with solutions on an individual basis.

Transcription:

For bladder cancer patients and their families, just like any cancer patients — or actually anybody else dealing with a non-COVID disease – this is an incredibly challenging time. Bladder cancer requires a lot of surveillance. And so, depending on what kind of bladder cancer you have, what stage is your disease and what kind of treatment is involved, there are a lot of questions and there are a lot of challenges right now.

Some patients need to see their doctors on a regular basis to be scoped, to see whether or not their cancer has returned. Some patients are getting treatment, maybe intravesical treatment into their bladder that has to be done on a weekly basis. There are patients that are getting chemotherapy. And all of this has changed during COVID because there’s a risk/benefit analysis you have to make. Do you go to see your doctor? Do you go to the hospital for that scope at a time where things might not be quite as safe or as comfortable as they were in non-COVID times?

So, what this requires is really a close relationship with your healthcare provider and having them talk with you about this risk/benefit analysis. There are many times that treatment can be delayed without impact on your prognosis and your health. But there are other times and other patients that treatment needs to happen now. But I think that most hospitals, as well as outpatient clinics and doctors’ offices, have taken all of the requisite steps to make sure that their patients are not unduly exposed to the risk of COVID when coming in for their treatments.

Again, this is why you need to talk with and have a good relationship with your medical team. They’re coming up with really creative and new ways and types of treatment that they can do during the time when surgery is not yet allowed. So, there are a lot of really interesting things going on, and a lot of helpful things going on.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Woman with dark brown hair and pink lipstick wearing a light pink blouse with a light brown blazer. Patients should have conversations with their providers about treatments after receiving diagnoses.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE
Sue Friedman in an interview with CURE
Related Content